Halozyme Therapeutics Inc (HALO)

Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell

$48.70

Buy

$49.40

arrow-up$1.04 (+2.17%)

Prices updated at 15 May 2025, 23:36 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Halozyme Therapeutics Inc is a biotechnology company. It is engaged in research on human enzymes that alter the extracellular matrix and tumor environment.
NASDAQ
arrow-down-0.18%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Biotechnology
Chairman
Mr. Jeffrey W. Henderson
CEO
Dr. Helen I. Torley, M.R.C.P.,MB.Ch.B.
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
350
Head office
12390 El Camino Real
San Diego
United States
92130
mobile
+1 858 794-8889
letter
ir@halozyme.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Mr. Jeffrey W. Henderson
Chairman of the Board
0.14m
Dr. Helen I. Torley, M.R.C.P.,MB.Ch.B.
Director, President and Chief Executive Officer
0.96m
Mr. Matthew L. Posard
Independent Director
0.06m
Ms. Barbara G. Duncan
Independent Director
0.09m
Ms. Bernadette M. Connaughton
Independent Director
0.07m
Mr. Mark Snyder
Senior Vice President, General Counsel, Chief Compliance Officer and Secretary
0.58m
Ms. Nicole LaBrosse
Senior Vice President, Chief Financial Officer and Principal Accounting Officer
0.57m
Ms. Moni Miyashita
Independent Director
0.06m
Dr. Mahesh Krishnan, M.B.A.
Independent Director
0.04m

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
BlackRock Inc17,092,111
Vanguard Group Inc12,831,503
BlackRock Fund Advisors10,332,734
State Street Corp7,184,636
Snyder Capital Management LP4,168,453

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
29 Nov 2024-
29 Nov 2024-
15 Oct 2024-
15 Oct 2024-
16 Oct 2024-
16 Oct 2024-
15 Oct 2024-
15 Oct 2024-
15 Oct 2024-
15 Oct 2024-
16 Oct 2024-
08 Oct 2024-
09 Oct 2024-
08 Oct 2024-
09 Oct 2024-
09 Oct 2024-
09 Oct 2024-
09 Oct 2024-
08 Oct 2024-
08 Oct 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.